What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Asthma
- Pathology
Her primary areas of investigation include Asthma, Immunology, Internal medicine, Respiratory disease and Family medicine.
Her research integrates issues of Eosinophilia, Physical therapy and Allergy in her study of Asthma.
Catherine Lemière interconnects Non-allergic rhinitis, Bilastine and Azelastine in the investigation of issues within Allergy.
Her work in Immunology tackles topics such as Eosinophilic which are related to areas like Thymic stromal lymphopoietin, Major basic protein and Bronchial Biopsy.
Her study focuses on the intersection of Internal medicine and fields such as Surgery with connections in the field of Exacerbation.
The concepts of her Family medicine study are interwoven with issues in Preventive healthcare, Young adult, Guideline, Asthma management and Work exacerbated asthma.
Her most cited work include:
- Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) (3245 citations)
- Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations (515 citations)
- TH17-associated cytokines (IL-17A and IL-17F) in severe asthma (435 citations)
What are the main themes of her work throughout her whole career to date?
Catherine Lemière focuses on Asthma, Occupational asthma, Internal medicine, Immunology and Physical therapy.
Her work carried out in the field of Asthma brings together such families of science as Respiratory disease, Inhalation, Family medicine, Allergy and Pediatrics.
Her research investigates the connection between Occupational asthma and topics such as Environmental health that intersect with problems in Work exacerbated asthma.
Her Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Anesthesia.
Her Immunology research includes elements of Airway and Eosinophilic.
Her Physical therapy study combines topics in areas such as Body mass index and Retrospective cohort study.
She most often published in these fields:
- Asthma (64.50%)
- Occupational asthma (32.47%)
- Internal medicine (27.71%)
What were the highlights of her more recent work (between 2015-2021)?
- Asthma (64.50%)
- Internal medicine (27.71%)
- Occupational asthma (32.47%)
In recent papers she was focusing on the following fields of study:
Her scientific interests lie mostly in Asthma, Internal medicine, Occupational asthma, Immunology and Mepolizumab.
Her Asthma study incorporates themes from COPD, Cohort study and Family medicine.
Her Internal medicine study which covers Anesthesia that intersects with Low dose.
Her research in the fields of Specific inhalation challenge overlaps with other disciplines such as High rate.
Catherine Lemière has researched Immunology in several fields, including Prednisone and Eosinophilic.
In her research, Allergy and Intensive care medicine is intimately related to Early detection, which falls under the overarching field of Disease.
Between 2015 and 2021, her most popular works were:
- Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia. (256 citations)
- Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels: A Randomized Phase 3 Study (246 citations)
- Reevaluation of Diagnosis in Adults With Physician-Diagnosed Asthma (177 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Asthma
- Pathology
Her primary scientific interests are in Asthma, Immunology, Internal medicine, Mepolizumab and Eosinophil.
Catherine Lemière combines subjects such as Prospective cohort study, Medical prescription and Emergency medicine with her study of Asthma.
Her Immunology research incorporates elements of Longitudinal study and Eosinophilic.
Her Internal medicine study focuses mostly on Occupational asthma and FEV1/FVC ratio.
Her Occupational asthma research is multidisciplinary, incorporating perspectives in Methacholine and Retrospective cohort study.
Her research in Mepolizumab intersects with topics in Discontinuation, Blood eosinophil, Open label, Post-hoc analysis and Disease.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
